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Adenovirus type 35 (Ad35) is a member of Ad subgroup B, DNA homology cluster B2. The B2 Ads are unique in that they
are isolated most frequently from immunosupressed individuals such as AIDS patients and bone marrow transplant recipients
and in that they have a tropism for the urinary tract. One region of the Ad genome which may influence serotype specific
pathology is early region 3 (E3). E3 of subgroup C Ad2 and Ad5 has been shown to encode proteins which counteract the
immune response to Ad infection. While a great deal is known about gene expression of the subgroup C Ad E3s, little is
known about the E3 gene expression from the subgroup B Ads. Although some E3 open reading frames (ORFs) are shared
between subgroups B and C, there are additional ORFs that appear in subgroup B. This paper demonstrates the results of
an analysis of gene expression from the Ad35 E3 and describes differences in splicing and polyadenylation between the
Ad35 and Ad2 E3s. RT–PCR, cDNA sequencing, RNase protection, 3* RACE, and Northern blotting techniques were utilized
to identify, quantify, and determine the structure of six Ad35 E3 mRNAs predicted to encode at least seven proteins. A
common intron that is removed during splicing of the subgroup C E3 mRNAs is not removed from Ad35 E3 mRNAs, and
only one E3 polyadenylation signal is present in the Ad35 E3 while two polyadenylation signals are used in the formation
of subgroup C E3 mRNAs. The quantity of individual mRNAs encoding homologous proteins for Ad35 and Ad2 also differ
substantially, presumably because of the absence in Ad35 of cis-acting signals which have been shown to be important
for regulation of Ad2 E3 pre-mRNA processing. Such information should contribute to an understanding of the role the E3
plays in determining subgroup B Ad pathogenesis in general and Ad35 pathogenesis in particular. q 1996 Academic Press, Inc.
INTRODUCTION The E3 of the subgroup C Ad2 encodes several pro-
teins, four of which have been shown to affect the hostAdenovirus type 35 (Ad35), which is most frequently
immune response. The E3 proteins which have beenisolated from immunosuppressed hosts such as renal
detected in infected cells are the 12.5-, 6.7-, 19-, 11.6-,transplant recipients, bone marrow transplant patients,
10.4-, 14.5-, and 14.7-kDa proteins, named, respectively,or AIDS patients (DeJong et al., 1983; Horwitz et al., 1984;
12.5K, 6.7K, 19K, 11.6K, 10.4K, 14.5K, and 14.7K. The 12.5KFlomenberg et al., 1987, 1994), is classified as a sub-
protein is produced in small amounts early and late ingroup B Ad. Subgroup B, which has been divided into
infection and has no known function. (Hawkins and Wold,clusters B1 and B2 based on genomic DNA homology
1992). The 11.6K protein is produced at low levels early(Wadell, 1984), is one of six subgroups of human adeno-
in infection and at increased levels late in infectionviruses (designated A–F) and contains several of the
(Scaria et al., 1992; Tollefson et al., 1992). The 11.6Kmore virulent adenovirus types (Horwitz, 1990). The B1
protein appears to facilitate release of virus particlesAds include Ad3 and Ad7 which can cause fatal, epi-
from the infected cell (Wold, 1995). The 6.7K and 19Kdemic pneumonia and Ad21 which can cause pneumonia
proteins are both endoplasmic reticulum (ER) residentand hemorrhagic cystitis. The B2 Ads include the urinary
proteins (Wilson-Rawls et al., 1990; Hawkins et al., 1993).tract pathogens Ads11, Ad34, and Ad35 as well as the
While the 6.7K has no known function, the 19K proteinrespiratory tract pathogen Ad14 (Horwitz, 1990). The mo-
is a glycoprotein (known as gp19K) which binds to andlecular determinants which influence the type of disease
retains class I MHC in the ER of infected cells, thuscaused by different Ad serotypes and subgroups are
preventing presentation of viral antigen to CD8/ T-cellspoorly understood. However, early region 3 (E3) of human
(Burgert et al., 1987; Pa¨a¨bo et al., 1987; Tanaka and Teve-adenoviruses appears to encode proteins which may in-
thia, 1988; Cox et al., 1990). The 14.7K protein is a solublefluence Ad pathogenesis by modulating the immune re-
cytoplasmic and nuclear protein (Tollefson and Wold,sponse to Ad infection (Wold, 1995).
1988) which prevents lysis of infected cells by TNFa
(Gooding et al., 1988, 1990; Horton et al., 1991). The 10.4K1 To whom reprint requests should be addressed at Albert Einstein
and 14.5K proteins are integral membrane proteins whichCollege of Medicine, Department of Microbiology and Immunology,
localize to the plasma membrane and have been shown1300 Morris Park Avenue, Bronx, New York 10461. Home: 718 601
7519. Fax: (718) 430-8702; E-mail: horwitz@aecom.yu.edu. to be involved in two functions. Coexpression of 10.4K
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and 14.5K protects some cells from lysis by TNFa (Good- by the subgroup C E3s (Signa¨s et al., 1986; Flomenberg
et al., 1988; Hong et al., 1988; Mei and Wadell, 1992,ing et al., 1991). Additionally, expression of 10.4K and
14.5K by Ad2 has been shown to cause downregulation 1993; Basler et al., 1995). The B1 Ads also encode an
ORF homologous to that which encodes the Ad2 11.6Kof type I and type II tyrosine kinase receptors including
the epidermal growth factor receptor (EGF-R) and the protein (Signa¨s et al., 1986; Hong et al., 1988), but this
ORF is absent from the B2 Ads (Flomenberg et al., 1988;insulin receptor (Carlin et al., 1989; Kuivinen et al., 1993).
Expression of 10.4K alone from a retroviral expression Mei and Wadell, 1992, 1993; Basler et al., 1995). The
structure of the subgroup B E3 mRNAs is also not known.vector has been shown to be sufficient to achieve down-
regulation of the EGF-R surface expression (Hoffman et Limited data suggest that there are splice acceptors up-
stream of each of the two 20K ORFs of the Ad3 E3 asal., 1990). Net EGF-R downregulation results from the
targeting of the EGF-R to the prelysosomal multivesicular well as splice acceptors upstream of the Ad3 ORFs ho-
mologous to the Ad2 14.5K and 14.7K ORFs (Signa¨s etbodies and its subsequent degradation (Hoffman and
Carlin, 1994). al., 1986). However, neither the overall structure nor the
exact splice sites of these mRNAs have been deter-Early in Ad infection, expression of E3 genes is driven
by the E3 promoter (Berk and Sharp, 1977). Late in infec- mined. No data have been published regarding the sub-
group B2 E3 mRNAs.tion, E3 genes can be expressed via the major late tran-
scription unit since the E3 lies between two families of This paper presents the Ad35 E3 mRNA structures
and quantities. These data should help in understandinglate Ad transcripts, the L4 and L5 families (Bhat and
Wold, 1986). Of note, the polyadenylation signal for the which E3 ORFs encode proteins synthesized during Ad35
infection. Additionally, knowledge of the abundance andL4 transcript family lies within the E3 region, but in Ad2-
infected cells, this L4 poly(A) site is active only in the the sequence context of the AUGs of each mRNA should
correlate with the amount of the E3 proteins translatedlate phase of viral gene expression (Brady et al., 1992).
At least seven alternatively spliced mRNAs are pro- from each mRNA. Comparative studies of the subgroup
B2 Ad35 and the subgroup C Ad2 E3 mRNAs may eluci-duced by the E3 of the subgroup C Ad2 (Wold, 1995).
The cis-acting signals required for proper Ad2 E3 splicing date molecular differences between these viruses which
potentially influence viral pathogenesis. Since the Ad2have been thoroughly analyzed and include two polyade-
nylation signals, an atypical AUUAAA, and a typical AAU- E3 has been used as a model for analyzing the regulation
of splicing and polyadenylation in a complex transcrip-AAA (Bhat and Wold, 1985). Four regions containing cis-
acting sequences which also regulate Ad2 E3 splicing tion unit, the structure and abundance of the Ad2 and
the Ad35 E3 mRNAs have been compared. This analysishave been identified (Bhat and Wold, 1985; Deutscher et
al., 1985; Bhat et al., 1986; Bhat and Wold, 1986; Brady may help refine our understanding of the cis-acting regu-
latory sequences which influence E3 pre-mRNA pro-et al., 1992; Scaria and Wold, 1994). Like the two poly(A)
sites, these regions are important for maintaining the cessing.
normal balance of E3 mRNA production. Analysis of Ad2
E3 RNAs has not only helped explain how the complex MATERIALS AND METHODS
E3 transcription unit functions, but has also facilitated
Cells and virus
analysis of E3 protein functions. Viruses containing dele-
tions within one E3 ORF often have unpredictably altered Initial reverse transcription–polymerase chain reac-
tion (RT–PCR) experiments were performed using HeLaE3 mRNA expression levels and thus protein expression
(Deutscher et al., 1985). cells, while subsequent experiments utilized 293 cells.
Cells were infected with Ad35 (103 to 104 particles/cellLittle is known about the gene expression from the
subgroup B E3 regions. The subgroup B1 and B2 E3s of Holden strain). Virus was added to 2–5 1 107 cells,
at a concentration of 1 1 107 cells/ml, in suspensioncontain ORFs homologous to the Ad2 12.5K, gp19K,
10.4K, 14.5K, and 14.7K proteins (Signa¨s et al., 1986; Flo- culture in the absence of serum, incubated with cells at
377 for 15 min before the cells were diluted to 1 1 106menberg et al., 1988; Hong et al., 1988; Mei and Wadell,
1992, 1993; Basler et al., 1995). Ad35, a subgroup B2 Ad, cells/ml with Joklik’s modified minimal essential medium
containing 5% fetal bovine serum. To enhance accumula-has been shown to produce a homologue of the Ad2
gp19K (Flomenberg et al., 1987). It has also been demon- tion of early viral mRNAs in Northern blotting experi-
ments, cycloheximide (25 mg/ml) was added at 2 hr post-strated that the B1 Ads produce proteins homologous to
the Ad2 gp19K and 14.7K (Pa¨a¨bo et al., 1986; Horton et infection (p.i.) (Bhat et al., 1986; Scaria and Wold, 1994).
Addition of cycloheximide to Ad2-infected cells does notal., 1990). In addition to these ORFs, a 20.5K protein has
been shown to be produced after Ad3 infection (Hawkins substantially affect the relative amounts of different Ad2
E3 mRNAs produced (Bhat and Wold, 1986b). For RT–and Wold, 1995), and its 20.6K homologue is produced
after Ad35 infection (unpublished data). The B1 and B2 PCR experiments and for RNase protection experiments,
cytosine arabinoside (AraC, 20 mg/ml) was added one-E3s also contain ORFs potentially encoding proteins of
approximately 15.0K and 20.3K which are not encoded half hour p.i. to prevent viral DNA synthesis, thus pre-
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venting the switch to late viral gene expression. Infec- viously used to determine E3 sequence (Basler et al.,
1995).tions were allowed to procede 9 hr in the presence of
cycloheximide or 12 hr in the presence of AraC.
RNase protection
Isolation of RNA Templates for RNase protection probes A, C, E, and
F, the sequences of which are indicated in Fig. 1, were
Total RNA was isolated using TRI Reagent (Molecular
amplified by PCR, using custom synthesized oligonucleo-
Research Center, Inc. Cincinnati, OH) according to the
tide primers and Ad35 genomic DNA as PCR template,
manufacturer’s instructions. Total RNA, used for RT–PCR
and the products cloned into pGEM-T or pT7Blue-T as
and Northern blotting experiments, was treated with 10
described for the RT–PCR methods. The resulting plas-
units RNase-free DNase I for 15 min at 377 in 80 mM
mids were linearized with restriction endonucleases, and
HEPES, pH 7.5, 12 mM MgCl2 , 10 mM NaCl, 10 mM DTT. antisense probes were transcribed using the Ambion
Cytoplasmic RNA was prepared following the protocol
Maxiscript In Vitro Transcription kit with T7, T3, or SP6
for isolation of cytoplasmic RNA from mammalian cells
RNA polymerase. Probes B and B* were transcribed with
outlined in Sambrook et al. (1989). Poly(A)/ RNA was
T3 RNA polymerase using as template pBSAdC (Basler
prepared using the Qiagen (Chatsworth, California) Oli-
et al., 1995) linearized with HpaI or SmaI, respectively.
gotex-dT mRNA isolation kit. One hundred to three hun-
Probe D was generated by removing the sequences be-
dred micrograms of cytoplasmic RNA from uninfected
tween the BamHI and XmaI sites from pBSAdPX (Basler
293 cells, from Ad35-infected 293 cells in the early phase
et al., 1995) and religating the plasmid, creating the plas-
of viral gene expression, or from Ad35-infected 293 cells
mid p10.4RNAP. p10.4RNAP was linearized by digestion
in the late phase of viral gene expression was bound to
with EcoRI, and probe D transcribed with T7 RNA poly-
Oligotex-dT suspension in binding buffer (10 mM Tris –
merase. RNA size marker was synthesized from Ambion
HCl, pH 7.5, 300 mM NaCl, 1 mM EDTA), washed twice
RNA Century Marker template using T7 RNA polymerase.
in wash buffer (10 mM Tris–HCl, pH 7.5, 150 mM NaCl,
Transcription reactions were diluted 1:1 in gel loading
1 mM EDTA), and eluted in 807 elution buffer (5 mM Tris –
buffer (80% formamide, 0.1% xylene cyanol, 0.1% brom-
HCl, pH 7.5).
phenol blue, 2 mM EDTA). Two microliters was removed,
diluted to 0.2 ml with ddH2O, and 2 ml of this mixture was
RT–PCR analysis of Ad35 early RNAs counted in a scintillation counter to determine total cpm/
reaction. The remaining probe was then gel purified. The
First-strand cDNA was synthesized using Gibco BRL
probe was heated to 957 for 3 min and run on a 5%
Superscript Reverse Transcriptase, according to the sup-
acrylamide/8 M urea/11 TBE (89 mM Tris, 89 mM boric
plier’s directions, on oligo(dT)-primed, DNase-treated, to-
acid, 2 mM EDTA) gel for 30 min at 300 V. The gel was
tal RNA from Ad35-infected HeLa or 293 cells. PCR reac-
subsequently exposed to Kodak XOMAT-AR film for 3–5
tions contained 10 mM Tris–HCl, pH 8.3, 1.5 mM MgCl2 , min until a band was visible on developed film. Using
50 mM KCl, 0.2 mM each dATP, dCTP, dGTP, dTTP, 2.5
the film to determine band position within the gel, the full-
units Taq DNA polymerase (Boehringer-Mannheim or
length probe (usually the strongest, highest molecular
Gibco BRL), 1 ml each primer, and 1 ml first-strand cDNA
weight band seen) was excised from the gel and eluted
diluted 1:10 or 1 ml Ad35 genomic DNA. PCR primers
by soaking the gel slice in 0.35 ml 0.5 M ammonium
used for RT–PCR analysis are shown in Fig. 1. Their
acetate, 1 mM EDTA, 0.2% SDS for 2–5 hr at 377. Two
sequence and location in the reported E3 sequence are
microliters of probe was counted in a scintillation counter
indicated in the legend to Fig. 1. Reactions were per-
to determine the amount of UTP incorporation.
formed in a Perkin–Elmer DNA Thermal Cycler. Reac-
RNase protection experiments were done using the
tions were incubated once at 947 for 7 min; at 947 for 1
Ambion RPAII RNase Protection Assay kit according to
min, 557 for 1 min, 727 for 1.5 min, for 25 cycles; and
manufacturer’s instructions using 1–3 mg of poly(A)/
once at 727 for 8 min. Reactions were analyzed on 1%
RNA or yeast total RNA per reaction. The entire RNase
agarose/11 TAE gels.
digestion sample was loaded on 5% acrylamide (19:1
RT–PCR reactions were extracted once with an equal
acrylamide:bisacrylamide) gel except for ‘‘undigested
volume of chloroform:isoamyl alcohol (24:1). Products
probe’’ samples (probe hybridized to yeast RNA and not
were then cloned by ligating the extracted PCR reaction
digested with RNase), of which only one-quarter of the
products to pGEM-T (Promega) or pT7Blue-T (Novagen)
sample was loaded on the gel.
DNA. Possible recombinant plasmids were screened for
by standard procedures. Plasmids containing the desired 3* RACE reactions
insert were purified according to manufacturer’s instruc-
tions on Qiagen midi- or maxiprep columns prior to se- 3* RACE (Rapid Amplification of cDNA 3* Ends) (Gibco
BRL) uses an adapter primer (AP) (5*GGCCACGCGTCG-quencing. Sequencing reactions were primed with T7 or
SP6 promoter primers or with appropriate primers pre- ACTAGTAC(dT)173*), an oligo(dT) primer with a defined
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(non-dT) sequence at its 5* end, to prime first-strand early phase of viral gene expression as template or in
cDNA synthesis. The oligo(dT) portion of AP hybridizes control reactions containing Ad35 genomic DNA as tem-
to the mRNA poly(A) tail to prime a reverse transcription plate. It should be noted that in PCR reactions containing
reaction. The defined sequence at the 5* end of AP is multiple templates with varying lengths of sequence be-
thus incorporated into all cDNA molecules synthesized. tween primer binding sites (i.e., cDNA from alternatively
PCR can then be carried out on the first-strand cDNA; a spliced mRNAs) the shorter-length templates will be pref-
universal amplification primer (UAP) (5*CUACUACUA- erentially amplified (Fejer et al., 1994). However, when
CUAGGCCACGCGTCGACTAGTAC3*), which is comple- there are multiple templates of approximately equal size
mentary to the defined sequence in AP, can then be used and amount, two bands have been observed (see below).
in conjunction with an upstream primer, which binds to PCR reactions done using primer 1 and primer 6 (Fig.
known sequences, to specifically amplify from the up- 1), complementary to sequences at the 3* end of the
stream primer to sites of mRNA polyadenylation. Primers 20.6-K ORF, resulted in the amplification of an approxi-
1, 2, and 5 (Fig. 1) were used as upstream primers for mately 2.56-kb product from Ad35 genomic DNA template
3* RACE reactions reported in this paper. and an approximately 1.3-kb product from cDNA (Fig. 2,
lanes 1 and 2). The 1.3-kb product was cloned, se-
Northern blotting quenced, and shown to correspond to a spliced E3
mRNA with an excised intron spanning nucleotidesTen micrograms of RNA size marker (Gibco BRL 0.24 –
1187–2418 of the published Ad35 E3 sequence. The9.5 kb RNA ladder) or approximately 15 mg, in 4.5 ml, of
splice donor had the sequence AG/GT at the exon/introntotal RNA from Ad35-infected cells in the early phase of
boundry and the splice acceptor had the sequence AG/viral gene expression was added to 17.5 ml of RNA sam-
CC at the intron/exon boundry, suggesting genuineple premix (6% formaldehyde, 46.5% formamide, 11
splice sites. In contrast, PCR reactions done with primerMOPS gel running buffer [20 mM MOPS, pH 7.0, 8 mM
1 and primer 3, complementary to sequences near thesodium acetate, 1 mM EDTA, pH 8.0, 1.4 mg/ml ethidium
bromide, and 14% loading dye (50% glycerol, 1 mM EDTA, 3* end of the 18.5K ORF, amplified approximately 1.3-kb
0.25% bromophenol blue, 0.25% xylene cyanol)]. Samples bands from both genomic DNA and cDNA (Fig. 2, lanes
were heated to 657 for 5 min, chilled on ice, centrifuged 4 and 5), suggesting that no splice acceptor is present
briefly, and loaded onto an agarose/formaldehyde gel. upstream of the 18.5K ORF in E3 mRNAs. Similarly, PCR
The gel (1.5% agarose, 11MOPS running buffer, 3% form- done using primer 1 and primer 4, complementary to the
aldehyde) was run in 11 MOPS running buffer at 120 V 3* end of the 20.3K ORF, amplified approximately 2.0 kb
for 4 hr. After electrophoresis, the gel was rinsed several on both cDNA and Ad35 genomic DNA, suggesting that
times in dH2O, photographed with a ruler under ultravio- no splice acceptor lies upstream of the 20.3K ORF (Fig.
let light transillumination, and soaked for 45 min in 400 3, lanes 1 and 2).
ml 101 SSC (201 SSC is 3 M NaCl, 0.3 M sodium citrate, PCR reactions done with common primer 1 and primer
pH 7.0). The RNA was then transferred to Hybond N/ 7, complementary to sequences within the 15.2K ORF,
(Amersham) nylon membranes by capillary action as de- amplified a 2.9-kb product from Ad35 genomic DNA (Fig.
scribed (Sambrook et al., 1989). RNA was fixed on the 4, lane 1) and two products of 1117 and 910 bp from
membrane by soaking in 50 mM NaOH for 5 min followed cDNA (Fig. 4, lane 2). The products amplified from cDNA
by a brief wash in 21 SSC. Membranes were blocked correspond to spliced mRNAs from which introns span-
by incubation in Amersham Rapid-Hyb buffer for at least ning nucleotides 1187–3008 (mRNA c) and nucleotides
15 min at 657. Heat-denatured probe (0.5–1 1 106 cpm/ 1187–3215 (mRNA d) were removed. These two splice
ml hybridization buffer) was added and hybridization con- acceptors lie upstream of the 10.3K and 15.2K ORFs,
tinued overnight at 657. Hybridized membranes were then respectively. The splice acceptor upstream of the 10.3K
washed twice for 15 min in 250 ml 11 SSC, 0.1% SDS ORF had the sequence AG/GT at the intron/exon bound-
at room temperature and twice for 15 min in 250 ml 0.11 ary, and the splice acceptor upstream of the 15.2K ORF
SSC, 0.1% SDS at 657. Membranes were allowed to air had the sequence AG/AC at the intron/exon boundry,
dry and then exposed to film. suggesting genuine splice sites. PCR reactions done
with primer 1 and primer 8, complementary to sequence
RESULTS within the 15.3K ORF, produced a 3.5-kb product using
Ad35 genomic DNA as template (Fig. 4, lane 3) and aInitial experiments examining the structure of the Ad35
1.2-kb product using cDNA as template (Fig. 4, lane 4).E3 mRNAs utilized a RT–PCR strategy. This strategy,
The 1.2-kb product corresponded to an mRNA from whichplaced in the context of the results, is presented in Fig.
an intron spanning nucleotides 1187–3679 was re-1. A common 5* primer and separate 3* primers, each in
moved. The splice acceptor had the sequence AG/TT ata different E3 ORF, were generated based on the E3
the intron/exon boundry, suggesting a genuine splicesequence and used in reactions containing either first-
strand cDNA generated from Ad35-infected cells in the acceptor.
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FIG. 1. The Ad35 E3 transcription unit and RNase protection strategy. The Ad35 mRNAs, the structures of which were determined by results
presented in this report, are indicated by arrows and are labeled a–f in italics. The unbroken portions of the arrows represent exons, and the
introns are indicated by breaks in the arrow. ORFs are shown as boxes above the mRNAs. An ORF is shown above the mRNA from which the
encoded protein is most likely translated, and the coordinates for each ORF are as follows: 12.2K, 687–1004; 15.0K, 958–1353; 18.5K, 1338–1838;
20.3K, 1858 –2403; 20.6K, 2421 – 2984; 10.3K, 3026–3301; 15.2K, 3306–3710; 15.3K, 3703–4110. The L4 and E3 polyadenylation signals are labeled
at the top of the figure. The arrowheads above the mRNAs represent PCR primers used in RT–PCR and 3* RACE reactions and are labeled 1–8
with underlined numbers. Primers correspond to the following coordinates in the reported Ad35 E3 sequence (Basler et al., 1995; Genbank Accession
No. U32664): primer 1, 433–452; primer 2, 1389–1405; primer 3, 1652–1680; primer 4, 2380–2403; primer 5, 2421–2444; primer 6, 2957–2984;
primer 7, 3346–3362; primer 8, 3909–3927. RNase protection probes are indicated by the thick-lettered (A–F) bars above the mRNAs. Probe B*
was used in Northern blotting experiments. The nucleotide positions of the splice sites, the RNase protection probe termini, and the AUG of the
20.3-K ORF are also indicated. The table to the right indicates the anticipated RNase protection product sizes based on the RT–PCR data. ‘‘Full-
length’’ refers to the length of probe colinear with unspliced segments of E3 mRNAs, the length of which is equivalent to the length of Ad35 genomic
DNA. ‘‘Spliced’’ refers to the length of the probe expected to be protected by a spliced E3 mRNA.
RNase protection A splice acceptor just upstream of this ORF would be
expected to yield a product of approximately 100 nucleo-
RNase protection experiments were performed to tides using probe A in an RNase protection experiment.
confirm the use of the splice sites detected by RT – However, only fully protected probe A was detected us-
PCR and to quantify Ad35 E3 mRNA levels by directly ing ‘‘early’’ mRNAs (Fig. 5) as well as after probing late
probing mRNA. A series of [32P]UTP-labeled, anti- phase mRNA (data not shown). Therefore, the RT–PCR
sense RNA probes (Fig. 1, A – F ) were generated. data and RNase protection data are concordant; no
These were hybridized to poly(A)/, cytoplasmic RNA splice acceptor upstream of the 20.3K ORF can be de-
from Ad35-infected cells in either the early phase or tected.
the late phase of viral gene expression. The relative Probe B, complementary to nucleotides 1251–1092,
abundance of each mRNA, as determined by RNase overlapped the splice donor at nucleotide 1186. Cyto-
protection, is indicated by the thickness of the arrows plasmic, poly(A)/ RNA from both the early phase (Fig. 6,
in Fig. 1. The expected-sized products, predicted lane 2) and the late phase (Fig. 6, lane 3) of Ad35 gene
based on the RT – PCR data, are indicated to the right expression protected a 94-nucleotide fragment of probe
of each probe. Examples of the types of results ob- B, indicating the use of the splice donor early and late in
tained with these probes are shown below. infection. Complete protection of the adenovirus derived
Probe A, complementary to nucleotides 1954–1662 sequences in probe B resulted in the protection of a 159-
nucleotide product indicating that the splice donor is not(Fig. 1), overlapped the 20.3K ORF by 96 nucleotides.
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band is not due to the presence of additional, alterna-
tively spliced mRNAs not detected by RT–PCR but rather
arises due to some property of the RNA–probe hybrid.
Therefore, the use of the splice acceptor at nucleotide
3009 has been demonstrated by RNase protection. The
expected full protection of probe D by mRNAs a and b
has also been demonstrated.
Probe E gave a result similar to probe D in that two
sets of doublets were seen instead of two single bands.
However, difficulties in producing full-length ‘‘positive con-
trol’’ RNA molecules for the probe E reactions have pre-
vented an unequivocal demonstration that the doublets
arise due to the properties of the RNA–probe E hybrids
(data not shown). Although the splice acceptor at nucleotide
3216 as well as full protection of probe E by mRNAs a–c
have been demonstrated, it cannot be absolutely excluded
that the additional bands seen in reactions performed using
probe E are due to the presence of alternatively spliced
E3 mRNAs not previously detected by RT–PCR. Reactions
performed with probe F clearly detected the use of the
splice acceptor at nucleotide 3596 as well as mRNAs a–FIG. 2. RT–PCR demonstrating a spliced mRNA to the 20.6K ORF
d. These reactions demonstrated that mRNA e is by far theand unspliced mRNA to the 18.5K ORF. PCR amplification was carried
out using primer 1, the E3 common 5* primer, in conjunction with primer most abundant Ad35 E3 mRNA, comprising approximately
6, to detect the 20.6K mRNA (lanes 1–3) or in conjunction with primer 50% of the total E3 mRNA.
3 to detect the 18.5K mRNA (lanes 4–6). Primer positions are indicated
in Fig. 1. PCR template was Ad35 genomic DNA (vDNA) in lanes 1 and Analysis of the 3* ends of the E3 mRNAs
4, and was oligo(dT)-primed, first-strand cDNA generated from Ad35-
infected 293 cells in the early phase of viral gene expression (cDNA) It was of interest to determine whether the mRNA
in lanes 2 and 5. No template was added in lanes 3 and 6. which appeared to be unspliced from primer 1 to primer
active in the formation of some of the E3 mRNAs either
early or late in infection.
Probe C also detected two bands of the expected mo-
lecular sizes (data not shown) indicating the use of the
splice acceptor at nucleotide 2419 as well as the pres-
ence of mRNA a, the formation of which requires that
this splice acceptor not function. RNase protection with
probe C demonstrated that mRNA b is the least abundant
Ad35 E3 mRNA.
Probe D, complementary to nucleotides 3224–2875,
overlapped the splice acceptor at nucleotide 3009. Two
products were expected, a 349-nucleotide product, due
to full protection of adenovirus sequences within the
probe, and a 215-nucleotide product due to the use of
the splice acceptor at nucleotide 3009. However, two
doublets were seen when probe D was hybridized to
mRNA from Ad35-infected cells in either the early phase
(Fig. 7, lanes 2–4) or late phase (data not shown) of
viral gene expression. A plus-sense, in vitro transcribed
positive control RNA, corresponding to the sequences FIG. 3. RT–PCR detecting only unspliced mRNA to the 20.3K ORF.
amplified by RT–PCR using primers 1 and 7, also yielded PCR was performed using primer 1, the common 5* primer, in conjunc-
tion with primer 4 to detect the 20.3K mRNA. (See Fig. 1 for primera doublet at the lower molecular weight (Fig. 7, lane 5).
position.) Template for the reaction shown in lane 1 was first-strandThe doublets appear to arise due to the internal cleavage
cDNA prepared from Ad35-infected cells in the early phase of viral
of some percentage of the RNA–probe hybrids. Since gene expression (cDNA). Template for the reaction shown in lane 2
the positive control RNA also gives a doublet near the was Ad35 genomic DNA (vDNA). A negative control reaction shown in
lane 3 contained no added template.215-nucleotide position, it is clear that the additional
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of mRNAs lies within the 12.2K ORF and includes the
sequence AAUAAA at nucleotides 993–998. When 3*
RACE was performed using the UAP and primer 1, a 600-
bp product was amplified, indicating the use of the L4
poly(A) site early during Ad35 infection (Fig. 9).
Northern blotting
In order to confirm the use of the L4 and ‘‘E3B’’ poly(A)
sites and to confirm the absence of other E3 poly(A) sites,
RNA blotting experiments were performed. RNA from
Ad35-infected cells in the early phase of viral gene ex-
pression was probed with either probe B*; which is com-
plementary to sequences at the 5* end of the E3 and
therefore should hybridize to all E3 mRNAs (Fig. 1), or
with probe F, which should hybridize to all mRNAs which
FIG. 4. RT–PCR of Ad35 E3 mRNAs for 10.3K, 15.2K, and 15.3K
ORFs. PCR was performed using primer 1, the common 5* primer, in
conjunction with primer 7 to detect the 15.2K mRNA (lanes 1 and 2) or
in conjunction with primer 8 to detect the 15.3K mRNA (lanes 3 and
4). (See Fig. 1 for primer position.) Template for the PCR reactions
shown in lanes 2 and 4 was first-strand cDNA prepared from Ad35-
infected 293 cells in the early phase of viral gene expression (cDNA).
Template for the PCR reactions shown in lanes 1 and 3 was Ad35
genomic DNA (vDNA).
4 at the 3* end of the 20.3K ORF (i.e., mRNA a) might
contain a splice 3* to the 20.3K ORF. In addition, it was
important to identify the poly(A) sites used in formation
of the Ad35 E3 mRNAs, as two poly(A) sites are used in
the formation of the Ad2 and Ad5 E3 mRNAs. Therefore,
3* RACE reactions were performed to examine the 3*
ends of the Ad35 E3 mRNAs and to define the location
of the E3 poly(A) sites.
First-strand cDNA synthesis was performed using the
‘‘adapter primer’’ (AP) hybridized to template mRNA iso-
lated from Ad35-infected cells in the early phase of viral
gene expression. PCR was then performed on the first-
strand cDNA using the ‘‘universal amplification primer’’
(UAP), complementary to the unique sequence in AP,
in conjunction with either primer 2, complementary to FIG. 5. RNase protection demonstrating no detectable spliced mRNA
to the 20.3K ORF. [32P]UTP-labeled, anti-sense probe A (see Fig. 1) wassequences at the 5* end of the 18.5K ORF, or primer 5,
hybridized to 1 mg cytoplasmic, poly(A)/ mRNA from Ad35-infected 293complementary to sequences at the 5* end of the 20.6-
cells in the early phase of viral gene expression (lane 1) or was hybrid-kDa ORF (Fig. 1). In each reaction, only a single product
ized to yeast RNA (lanes 2 and 3). Reactions 1 and 2 were digested
was amplified, the size of which corresponded to the with RNase A and T1 as described under Materials and Methods.
distance from the primer to the 3* end of the Ad35 E3 Reaction 3 was not digested with RNase and only one-quarter of the
total reaction was loaded on the gel. The arrow indicates the unsplicedregion (Fig. 8, lanes 1 and 3). Therefore, only one poly(A)
form of the mRNA detected by probe A. ‘‘Undigested’’ product, such assite downstream of the 18.5K ORF is used in the forma-
in lane 3, is of greater molecular size than ‘‘full-length’’ product, suchtion of Ad35 E3 mRNAs. Additionally, no splice sites
as in lane 2, because both viral and plasmid sequences are transcribed
downstream of the 18.5K ORF on mRNA a or the 20.6K during probe synthesis. The plasmid sequences are present in ‘‘undi-
ORF on mRNA b were detected (see Fig. 1). gested’’ product but not in ‘‘full-length’’ product. (See Fig. 1 for schematic
of mRNAs and probes.)The poly(A) site used for formation of the L4 family
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10, lane 3) The structure of the molecule represented by
the upper b* band in the doublet is unknown.
DISCUSSION
This report presents the first map of the mRNAs pro-
duced by the immunoregulatory E3 region of a subgroup
B Ad and presents the first data describing any aspect
of the subgroup B2 Ad E3 mRNAs. There are several
significant differences between Ad35 and the subgroup
C Ad2 with regard to the abundance and structures of
E3 mRNAs encoding homologous proteins (Fig. 11). The
Ad35 10.3K, 15.2K, and 15.3K ORFs, encoding homo-
logues of the Ad2 anti-TNFa proteins 10.4K, 14.5K, and
14.7K, respectively, are encoded by mRNAs c, d, and e.
Data from the RNase protection and the Northern blots
presented above indicate that mRNAs d and e are the
two most abundant Ad35 E3 mRNAs comprising approxi-
mately 20 and 48%, respectively, of the total Ad35 E3
mRNAs. mRNA c, encoding the 20.6K protein comprises
approximately 3–8% of the Ad35 E3 mRNAs. Additionally,
mRNA a, which should primarily encode the Ad35 class
I MHC binding protein, 18.5K, and perhaps also the 20.3K
FIG. 6. RNase protection demonstrating the use of the common
5* splice site. [32P]UTP-labeled anti-sense probe B (lanes 1–5) was
hybridized to 1 mg cytoplasmic, poly(A)/ mRNA from uninfected 293
cells (lane 1), from Ad35-infected cells in the early phase of viral gene
expression (lane 2), or from Ad35-infected 293 cells in the late phase
of viral gene expression (lane 3). Probes were also hybridized to yeast
RNA (lanes 4 and 5). All reactions were digested with RNase A and
T1 except those shown in lane 5. One-quarter of samples from reaction
5 was loaded on the gel. The entire reaction was loaded on the gel
for the remainder of the reactions. The upper arrow (159) on the left
indicates the position of the unspliced E3 mRNA a which does not use
the common 5* splice site and is therefore colinear with probe B. The
lower arrow indicates the product protected by spliced mRNAs b–e
which use the 5* splice site. (See Fig. 1 for schematic of mRNAs and
probes.)
terminate at the ‘‘E3B’’ poly(A) site but not to mRNAs
which hybridize to an ‘‘E3A’’ poly(A) site upstream of
probe F (Fig. 1). Comparison of the bands produced after
hybridization to probe B* (Fig. 10, lane 1) to the bands
produced after hybridization to probe F (Fig. 10, lane 2)
indicates that only one mRNA terminates 5* to probe F.
FIG. 7. RNase protection detecting a splice to the 10.3K ORF. [32P]-
This mRNA appears to be approximately 800 nucleotides UTP-labeled anti-sense probe D was hybridized to 1 mg of cytoplasmic,
long, roughly the size expected of a polyadenylated tran- poly(A)/ RNA from uninfected 293 cells (lane 1) or increasing concen-
trations of cytoplasmic, poly(A)/ RNA from Ad35-infected 293 cells inscript which initiates at the E3 promoter and which termi-
the early phase of viral gene expression (lanes 2–4). Probe D wasnates at the L4 poly(A) site. Therefore, in agreement with
also hybridized to an in vitro synthesized positive-sense positive controlthe 3* RACE data, no ‘‘E3A’’ poly(A) site was found by
RNA corresponding to the 10.3K mRNA encoding RT–PCR product
blotting experiments. The same mRNA was also probed amplified by primers 1 and 7 (see Fig. 4, lane 2) and to yeast RNA
with probe E (Fig. 10, lane 3), which should hybridize to (lanes 6 and 7). All reactions were digested with RNase A and T1
except reaction 7 which was not digested with RNase. One-quarter ofall mRNAs except e and f (Fig. 1). This experiment con-
reaction 7 was loaded on the gel, while all of the remaining reactionsfirmed the identity of the lowest band as mRNA f, the
were loaded on the gel. The upper arrow (349) indicates the productnext band as mRNA e, followed in increasing molecular
protected by mRNAs a and b which are colinear with probe D. The
size by mRNAs d, c, b, b*, and a. Of note, probes B* and lower arrow (215) indicates the product protected by spliced mRNA c
F hybridized to a b doublet (Fig. 10, lanes 1 and 2), while which corresponds to the 215-nucleotide product predicted by RT–
PCR. (See Fig. 1 for schematic of mRNAs and probes.)probe E hybridized to only the lower, mRNA b band. (Fig.
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FIG. 8. 3* RACE demonstrating usage of an ‘‘E3B’’ polyadenylation
site but not an ‘‘E3A’’ site. PCR amplification of first-strand cDNA primed
with the ‘‘adapter primer’’ (AP) was performed using the universal ampli-
fication primer (UAP), which is homologous to unique sequences at
the 5* end of AP, in conjunction with the indicated primers. Reactions
used UAP and primer 2, the 18.5K primer (lanes 1 and 2) or primer 5,
the 20.6K 5* primer (lanes 3 and 4). Reactions contained cDNA template
FIG. 10. Northern blot analysis of Ad35 early RNA. Total RNA isolated(lanes 1 or 3) or no template (lanes 2 and 4). See Materials and Methods
from Ad35-infected 293 cells in the early phase of viral gene expressionfor an explanation of the 3* RACE reaction, and see Fig. 1 for position
was probed with [32P]UTP-labeled, anti-sense RNA probe B*, whichof 5* primers.
binds the 5* end of the E3 (lane 1); probe F, which binds near the 3*
end of the E3 (lane 2); or probe E, which binds within the 15.2K ORF
(lane 3). (See Fig. 1 for position of probes within the Ad35 E3.) RNAprotein (see below), comprises only 9–12% of the Ad35
was electrophoresed on 1.5% agarose/formaldehyde/11 TBE gels,E3 mRNA, calculated from results obtained with probes transferred to nitrocellulose, and probed as indicated above.
B and A and from Northern blotting data. For reasons
which have not been resolved, Ad35 mRNA a appeared
probe C. In contrast, the subgroup C Ads 2 and 5 devoteto be of lower abundance in experiments done using
nearly half of their E3 mRNAs to the production of mRNAs
a and c which encode the class I MHC binding protein
gp19K and relatively less mRNA to the production of
the anti-TNFa 10.4K, 14.5K, and 14.7K proteins (Fig. 11,
mRNAs f and h) (Wold, 1995).
The differences in levels of E3 mRNAs encoding Ad35
and Ad2 E3 protein homologues are likely a reflection of
differences in the cis-acting sequences affecting pre-
mRNA processing in the Ad35 and Ad2 E3 regions. It
has previously been noted that Ad35 as well as other
subgroup B2 Ads lack an E3 ORF homologous to the
ORF encoding the 11.6K protein encoded by the Ad2 E3
(Flomenberg et al., 1988; Mei and Wadell, 1992). A series
of publications have demonstrated that cis-acting se-
quences within the Ad2 11.6-kDa ORF suppress splicing
from the splice donor at nucleotide 951 to the splice
acceptors which form the anti-TNFa protein encoding
mRNAs (Deutscher et al., 1985; Bhat et al., 1986; Bhat
and Wold, 1986; Scaria and Wold, 1994). When these cis-
FIG. 9. 3* RACE demonstrating early usage of the L4 poly(A) site in acting sequences are deleted from the Ad2 E3, the use
Ad35. PCR amplification of first-strand cDNA primed with the ‘‘adapter of the splice donor at nucleotide 951 increases, and the
primer’’ (AP) was performed using the universal amplification primer
abundance of mRNAs a and c, the formation of which(UAP), which is complementary to the 5* end of AP, in conjunction with
require inactivity of this splice donor, decreaseprimer 1, the common 5* primer. The left lane shows the size markers;
the right lane is the 3* RACE product. (Deutscher et al., 1985; Bhat et al., 1986; Bhat and Wold,
/ m4950$7661 12-14-95 10:31:52 vira AP-Virology
174 BASLER AND HORWITZ
FIG. 11. Comparison of Ad35 and Ad2 E3 mRNAs. The structures of the Ad35 E3 and Ad2 E3 mRNAs are depicted below. Each arrow represents
a separate mRNA molecule designated, at left, according to the letter by which it is referred in the text. Gaps in the arrows indicate introns. Hatched
portion of the arrows indicate sequences which are deleted relative to the other virus. The boxes indicate the position of open reading frames
expected to encode proteins, the molecular weights of which are indicated within the boxes. The numbers indicate the coordinates of splice donors
and acceptors which are referred to under Results and/or Discussion. Polyadenylation sites are labeled with large, bold labels according to the
designation (L4, E3A, or E3B) used to refer to the site in the text. Alignment of the Ad35 and Ad2 sequences indicates that the Ad35 splice donor
at position 1186 and the Ad2 splice donor at position 951 lie within homologous sequences.
1986). The absence of such cis-acting sequences from 2157, resulting in increased mRNA f production and a
decrease in mRNA a production (Deutscher et al., 1985;the subgroup B2 Ad35 E3 may thus contribute to the
relatively larger amount of splicing from the common Bhat et al., 1986; Bhat and Wold, 1986). Since Ad35 ap-
pears to be a natural E3A ‘‘mutant,’’ this may also contrib-splice donor at nucleotide 1186 to downstream acceptors
and the relatively lesser amount of the mRNA in which ute to this relative increase in splicing (compared to Ad2)
to downstream splice sites which encode the anti-TNFathe splice donor at nucleotide 1186 is not used (mRNA
a). Additionally, it has been demonstrated that the pres- proteins.
The differences in abundance of various mRNAs likelyence of the E3A poly(A) site in the Ad2 E3 is essential
for the accumulation of large amounts of mRNA a. This leads to differences in the abundance of the Ad35 E3
proteins. Therefore, the Ad35 E3, compared with the cor-report demonstrates that the Ad35 E3 lacks an E3A
poly(A) site. When the Ad2 E3A poly(A) site is deleted, responding Ad2 E3 proteins, may produce more of the
anti-TNFa proteins 10.3K, 15.2K, and 15.3K and relativelyan apparent competition between splicing and polyade-
nylation processes is relieved. This results in an increase less 18.5K. The RNA data, suggesting that Ad35 devotes
only 10% of its E3 mRNA to 18.5K production while Ad2in splicing to the splice acceptor at Ad2 E3 nucleotide
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devotes 50% of its E3 mRNA to gp19K production, is lated in Ad35-infected cells, it would appear to be en-
coded by mRNA a. Synthesis of the 20.3K would requiresupported by observations of class I MHC binding pro-
tein production in Ad35- versus Ad2-infected cells. When either reinitiation of translation, where the 18.5K protein
translation is initiated first, followed by translation termi-HeLa cells were infected with equal multiplicities of in-
fection with either Ad35 or Ad2, the Ad35-infected cells nation and reinitiation, or by an internal initiation of trans-
lation. It has been suggested that the Ad2 E3 14.5K pro-were found to produce approximately one-fifth as much
virally encoded glycoprotein (Flomenberg et al., 1987). tein is produced from the same mRNA as the Ad2 10.4K
protein by a reinitiation mechanism (Tollefson et al.,This is of significance since gp19K (or 18.5K) acts stoi-
chiometrically, binding directly to class I MHC and pre- 1990).
The 20.6K encoding mRNA b is the least abundantventing its transit to the cells surface (Kvist et al., 1978;
Burgert et al., 1985). If less gp19K (or 18.5K) is made, Ad35 E3 mRNA. Low abundance of this mRNA is also
reflected by the observation that the Ad35 20.6K proteindownregulation of class I MHC from the cell surface is
likely to be less efficient. Such differences could poten- is made at low levels in infected cells and visualization
of the 20.6K by immunoprecipitation requires long expo-tially influence the ability of the viruses to cause acute
disease or their ability to establish persistent infection. sures to film (unpublished observation). Recently, the Ad3
and Ad7 homologues of the 20.6K protein were shownIt is less clear what the significance of increased anti-
TNFa protein levels might have on viral replication or to be produced during infection (Hawkins and Wold,
1995). A function for either the 20.3K or the 20.6K is notpathogenesis; the amount of these proteins required for
effective function is unknown. obvious based on sequence analysis. Presumably, these
proteins are required in small amounts to carry out theirThe 20.3K and 20.6K ORFs of Ad35 do not have homo-
logues in the E3 regions of the subgroup A (Ad12) function.
The 12.2K ORF, the ATG which likely initiates transla-(Sprengel et al., 1994), C (Ads2 and 5) (Herisse et al.,
1980; Herisse and Galibert, 1981; Cladaras and Wold, tion of the 15.0K protein, and a large portion of the 15.0K
ORF are present on all the Ad35 E3 mRNAs (Fig. 1).1985), or F (Ads 40 and 41) (Davison et al., 1993). Homo-
logues of these ORFs are, however, conserved among However, neither the 12.2- nor the 15.0-kDa initiating ATG
is in the sequence context (PyNNATGPy) which wouldall of the B1 (Ads 3 and 7) (Signa¨s, 1986; Hong et al.,
1988) and B2 (Ads 11 and 35) (Flomenberg et al., 1988; promote efficient initiation of translation (reviewed in Ko-
zak, 1992). Therefore, the scanning model of translationMei and Wadell, 1992; Basler et al., 1995) E3s sequenced
thus far. No splice acceptor was found upstream of the initiation may account for the read-through of these
ATGs; the 12.2K and 15.0K ATGs could be bypassedAd35 20.3K ORF. This contrasts with data from the Ad3
E3 region. An S1 nuclease mapping experiment on mRNA by the 40S ribosomal subunit, permitting expression of
downstream ORFs which are in better context for transla-from Ad3-infected cells found a low abundance mRNA
which appeared to be spliced immediately upstream of tion initiation. The presence of ATGs in an inefficient
context for translation but which are known to functionthe 20.1K ORF. The exact splice site and structure of this
mRNA, however, were not determined (Signa¨s, 1986). in translation initiation has precedent in the Ad2 E3. In
Ad2, the 12.5K initiating ATG is present on all the Ad2A similar mRNA was not found in Ad35-infected cells.
Interestingly, the Ad3 contains the sequence Py10ACAG- E3 mRNAs and the 6.7K initiating ATG is present on two
of the Ad2 E3 mRNAs (Wold, 1995). Each of these pro-CATG (Signa¨s, 1986) while the Ad35 contains the se-
quence Py3ACAGACATG (Flomenberg et al., 1988) near teins is produced in minor amounts compared with other
E3 proteins produced from the same mRNAs (Hawkinsthe start of the 20.3K ORF. Neither of these sequences
conforms precisely to the mammalian splice acceptor and Wold, 1992; Wilson-Rawls et al., 1990). The presence
of an intron which is removed from all but one Ad2 E3consensus sequence PynNPyAGG, where the under-
lined sequence is highly conserved (reviewed in Green, mRNA species results in the removal of much of the Ad2
12.5K ORF (Wold, 1995). Therefore, the Ad2 E3 mRNAs1991), but it is possible that the difference in the length
of the polypyrimidine tract upstream of the 20.3K ORF do not encode this protein in its entirety, and it can only
be translated from minor E3 mRNA i and a minor latecontributes to the differences in splicing 5* to the 20.3K
ORF. The polypyrimidine tract binds the U2 snRNP auxil- mRNA (Hawkins and Wold, 1992). In contrast, each of
the Ad35 E3 mRNAs potentially encodes the entire 12.2Kiary factor which facilitates U2 snRNP binding to the pre-
mRNA (Green; 1991). Lengthening a polypyrimidine tract protein. Additionally, the existence of mRNA f, which orig-
inates at the E3 promoter and terminates at the L4 poly(A)can improve splicing to an inefficient 3* splice site (Bouk
et al., 1995). The sequence between the 18.5K ORF stop site, potentially encodes the 12.2K protein as well. (It
has not been determined, however, whether mRNA f iscodon and the 20.3K ATG is identical in Ad35 and two
subtypes of Ad11 (Mei and Wadell, 1992). It therefore efficiently transported to the cytoplasm.) It is therefore
possible that Ad35 will produce a relatively larger amountseems likely that Ad11, like Ad35, will not utilize a splice
site upstream of its 20.3K ORF to produce a 20.3K encod- of its 12.2K protein compared with the Ad2 12.5K. In
addition, the Ad35 E3 mRNAs potentially encode a familying mRNA early in infection. If the 20.3K protein is trans-
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